Immunomedics (IMU) Investor Presentation - Slideshow

1/31/17

By Seeking Alpha

The following slide deck was published by Immunomedics, Inc. in conjunction with this event.

119

0 36 108 IMMUNOMEDICS, INC. 31 63 125 255 76 0 Advanced Antibody-Based Therapeutics 252 145 63 Oncology 252 174 113 Autoimmune Diseases 0 24 70 Setting the Record Straight: 175 165 147 131 126 116 Immunomedics is Acting in the Best Interests of 114 90 48 All Stockholders to Maximize Near-Term Value 215 208 196 171 176 186 January 2017 242 242 242 213 227 255

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.

Sponsored -
Agency/Corporate Program

MG+M Elevates Attorneys Stephanie Chesney and Shannon O’Neil Partner

MG+M The Law Firm (MG+M) is pleased to announce that it has elevated attorneys Stephanie M. Chesney

Burns & Levinson Adds Leading Plaintiff Employment Litigator Beth Myers as a Partner

Burns & Levinson announced today that well-known plaintiff employment litigator Beth R. Myers has joined the firm

BayCoast Bank Names Nicole Almeida as SVP, Chief Diversity Officer

BayCoast Bank is delighted to announce Nicole Almeida as Senior Vice President, Chief Diversity Officer (CDO)

BayCoast Bank Appoints Robert Bergdoll as First VP Marketing Director

BayCoast Bank is pleased to announce Robert Bergdoll of Attleboro, Massachusetts, as First Vice President Marketing Director

TRUSTED BY
THESE PARTNERS: